Nordic EMBL Partnership Launches Institute for Molecular Medicine Finland
March 25, 2010
Nordic EMBL Partnership Launches Institute for Molecular Medicine Finland
FIMM studies cancer, as well as cardiovascular, neuro-psychiatric and viral diseases, carries out translational research, and seeks to promote human health through research on personalized medicine.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Finnish Institute to Use Labcyte Tech to Enhance Cancer Testing Studies
January 7, 2013 / GenomeWeb Daily News - Phadia to Use Aushon 2470 Arrayer for Development of Allergen and Autoimmunity Diagnostics
June 25, 2010 / ProteoMonitor - Institute for Molecular Medicine Finland Adopts Aushon Arrayer for Cell-Screening Program
March 30, 2010 / BioArray News - Finland Adds $2.6M for European Translational Research Effort
February 3, 2010 / GenomeWeb Daily News